| ■ 영문 제목 : In-vitro Toxicology Testing Market Size, Share & Trends Analysis Report By Technology (Cell Culture, High Throughput), By Method, By Application, By End-user, By Region, And Segment Forecasts, 2023 - 2030
|
 | ■ 상품코드 : GRV23MA026
■ 조사/발행회사 : Grand View Research
■ 발행일 : 2023년 1월
■ 페이지수 : 180
■ 작성언어 : 영어
■ 보고서 형태 : PDF
■ 납품 방식 : E메일 (납기:3일)
■ 조사대상 지역 : 세계
■ 산업 분야 : 의료
|
■ 판매가격 / 옵션
(부가세 10% 별도)
| Single User (1인 열람용) | USD5,950 ⇒환산￦8,032,500 | 견적의뢰/주문/질문 |
| Multi User (5인 열람용) | USD6,950 ⇒환산￦9,382,500 | 견적의뢰/주문/질문 |
| Global/corporate License (기업 열람용) | USD8,950 ⇒환산￦12,082,500 | 견적의뢰/구입/질문 |
※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.
|
미국 Grand View Research (그랜드뷰리서치)는 세계의 체외 독성 검사 시장 규모가 2023년부터 2030년 사이에 연평균 11.1% 성장하여, 2030년에는 647억 달러에 달할 것으로 전망하고 있습니다. 본 조사 자료는 세계의 체외 독성 검사 시장을 조사대상으로 하여, 조사 방법 및 범위, 개요, 시장 변동/동향/범위, 최종 용도별 (제약 산업, 화장품 및 가정 용품, 학술기관 및 연구소, 진단, 기타) 분석, 기술별 (세포 배양 기술, 하이 스루풋 기술, 분자 이미징, 오믹스 기술) 분석, 용도별 (전신 독성, 경피 독성, 내분비 교란, 안독성, 기타) 분석, 기법별 (세포 분석, 생화학 검정, 인실리코, 엑스비보) 분석, 지역별 (북미, 유럽, 아시아 태평양, 중남미, 중동/아프리카) 분석, 경쟁 현황 등의 내용을 게재하고 있습니다. 또한 본 자료는 Charles River Laboratories International, Inc., Thermo Fisher Scientific, Inc., Abbott Laboratories, Sgs S.A., Laboratory Corporation Of America Holdings, Merck Kgaa, Eurofins Scientific, Evotec S.E., Agilent Technolgies Diagnostics Incorporated, Danaher Corporation, Bio -Rad Laboratories, Inc., Catalent, Inc., Bioivt, Gentronix 와 같은 기업 정보를 포함하고 있습니다.
・조사 방법 및 범위
・개요
・시장 변동/동향/범위
・세계의 체외 독성 검사 시장 규모 : 최종 용도별
- 제약 산업에서 사용되는 체외 독성 검사의 시장 규모
- 화장품 및 가정 용품에 사용되는 체외 독성 검사의 시장 규모
- 학술기관 및 연구소의에서 사용되는 체외 독성 검사의 시장 규모
- 진단에 사용되는 체외 독성 검사의 시장 규모
- 기타 최종 용도에 사용되는 체외 독성 검사의 시장 규모
・세계의 체외 독성 검사 시장 규모 : 기술별
- 세포 배양 기술의 시장 규모
- 하이 스루풋 기술의 시장 규모
- 분자 이미징 기술의 시장 규모
- 오믹스 기술의 시장 규모
・세계의 체외 독성 검사 시장 규모 : 용도별
- 전신 독성 시험의 시장 규모
- 경피 독성 시험의 시장 규모
- 내분비 교란 시험의 시장 규모
- 안독성 시험의 시장 규모
・세계의 체외 독성 검사 시장 규모 : 기법별
- 세포 분석의 시장 규모
- 생화학 검정의 시장 규모
- 인실리코의 시장 규모
- 엑스비보의 시장 규모
・세계의 체외 독성 검사 시장 규모 : 지역별
- 북미의 체외 독성 검사 시장 규모
- 유럽의 체외 독성 검사 시장 규모
- 아시아 태평양의 체외 독성 검사 시장 규모
- 중남미의 체외 독성 검사 시장 규모
- 중동/아프리카의 체외 독성 검사 시장 규모
・경쟁 현황
・기업 정보 |
■ 보고서 개요In-vitro Toxicology Testing Market Growth & Trends
The global in-vitro toxicology testing market size is projected to reach USD 64.7 billion by 2030, at a CAGR of 11.10% over the forecast period, according to a new report by Grand View Research, Inc. Over the years, acceptance of in-vitro toxicology testing methods by regulatory authorities is increasing at a faster pace & thus validation of these tests methods opposed to conventional testing is even rising. Also, development of technologies to substitute animal use for toxicology tests has fueled the usage of in-vitro models such as in-silico simulation, assays, 3D cell cultures and many more, thereby boosting market growth.
Screening of a new drug candidate involves the use of animals for preclinical studies which is very tedious and expensive. However, in recent times, several jurisdictions are promoting ban for animal-based chemical testing. For example, for several years, the EU has been promoting the reduction, replacement, and refinement of animal tests. The Regulation on cosmetic products (1223/2009), REACH (2007/2006), the Directive on the protection of animals used for scientific purposes (2010/63), and Classification, Labelling and Packaging (CLP) (1272/2008) are some examples of EU legislation that are engaged in strongly encouraging the replacement of animal toxicology testing. Furthermore, in June 2018, the Cruelty-Free Cosmetics Act was passed in California to ban the selling of animal-tested products after 2020.
Many governments and private organization are taking actions to minimize conventional testing models, providing funds to support & develop in-vitro toxicology assays and form conducive government policies. Thus, increase in government initiatives that are focused on banning animal testing can be attributed to the rise in adoption of in-vitro toxicological models and creates many opportunities within the market. For instance, approximately USD 3.2 million were contributed by People for the Ethical Treatment of Animals (PETA) and its international associates to promote the development of non-animal test methods.
The advancements in computational and screening methods such as biological, high throughput, and chemical coupled with the vast number of public databases for toxicity analysis has expanded largely. This has allowed researchers to access information for drug discovery studies, toxicology profiling, and drug development programs. For instance, the MetaTox HS project by Agilent Technologies, Inc. brings advanced solutions for toxicity assays & high sensitivity metabolism during drug development procedures.
In-vitro Toxicology Testing Market Report Highlights
• Based on technology, the cell culture segment held the largest revenue share in 2022, owing to the increased demand for accurate & cost-effective analysis. Moreover, the adoption of 3D cell culture is also propelling the growth of this segment
• On basis of application, the system toxicology segment dominated the market for in-vitro toxicology testing in 2022. Generation of toxicology data points such as minimum dose, tolerated dose, risk assessment and many more will contribute to the revenue generation
• The cellular assays segment accounted for the highest revenue share in 2022, owing to the developments in cell-based imaging assays, high throughput screening & label-free detection
• The pharmaceutical industry as an end-user contributed the largest revenue to the market in 2022. The importance of toxicology testing during drug development stages coupled with high number of product pipeline attributes to the revenue generation
• North America accounted for the highest revenue share in 2022 due to prevalence of animal testing bans & supportive government initiatives for toxicology research. In addition, aggregation of players in this regions to provide in-vitro testing product and services will continue the revenue generation during the forecast
■ 보고서 목차Table of Contents
Chapter 1 Methodology and Scope
1.1 Research Methodology
1.2 Research Assumptions
1.2.1 Estimates And Forecast Timeline
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
Chapter 2 Executive Summary
2.1 Market Snapshot
2.2 Segment Snapshot
2.3 Competitive Landscape Snapshot
Chapter 3 Market Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.2 In-vitro Toxicology Testing Market: Cost Structure Analysis
3.3 Market Trends & Outlook
3.4 Market Dynamics
3.4.1 Market Driver Analysis
3.4.1.1 Rise In Government Funding For Toxicology Research
3.4.1.2 Opposition To Animal Testing
3.4.1.3 Ongoing Developments To Adavnce Toxicology Research
3.4.2 Market Restraint Analysis
3.4.2.1 Lack of in-vitro models
3.4.2.2 Issues pertaining to standarization of in-vitro studies
3.5 Penetration &Growth Prospect Mapping, 2022
3.6 In-vitro Toxicology Testing Market – Porter’s Analysis
3.7 In-vitro Toxicology Testing Market – SWOT Analysis
3.8 COVID-19 Impact Analysis
Chapter 4 End-user Business Analysis
4.1 In-vitro Toxicology Testing Market: End-user Movement Analysis
4.2 Pharmaceutical Industry
4.2.1 In-Vitro Toxicology Market For Pharmaceutical Industry, 2018 – 2030 (USD Million)
4.3 Cosmetics & Household Products
4.3.1 In-Vitro Toxicology Market For Cosmetics And Household Products, 2018 – 2030 (USD Million)
4.4 Academic Institutes & Research Laboratories
4.4.1 In-Vitro Toxicology Market For Academic Institutes & Research Laboratories, 2018 – 2030 (USD Million)
4.5 Diagnostics
4.5.1 In-Vitro Toxicology Market For Diagnostics, 2018 – 2030 (USD Million)
4.6 Chemicals Industry
4.6.1 In-Vitro Toxicology Market For Chemicals Industry, 2018 – 2030 (USD Million)
4.7 Food Industry
4.7.1 In-Vitro Toxicology Market For Food Industry, 2018 – 2030 (USD Million)
Chapter 5 Technology Business Analysis
5.1 Global In Vitro Toxicology Testing Market: Technology Movement Analysis
5.2 Cell Culture Technology
5.2.1 In-Vitro Toxicology Market For Cell Culture Technology, 2018 – 2030 (USD Million)
5.3 High-Throughput Technology (Htt)
5.3.1 In-Vitro Toxicology Market For Htt, 2018 – 2030 (USD Million)
5.4 Molecular Imaging
5.4.1 In-Vitro Toxicology Market For Molecular Imaging, 2018 – 2030 (USD Million)
5.5 Omics Technology
5.5.1 In-Vitro Toxicology Market For Omics Technology, 2018 – 2030 (USD Million)
Chapter 6 Application Business Analysis
6.1 In-Vitro Toxicology Testing Market: Application Movement Analysis
6.2 Systemic Toxicology
6.2.1 In-Vitro Toxicology Market For Systemic Toxicology, 2018 – 2030 (USD Million)
6.3 Dermal Toxicity
6.3.1 In-Vitro Toxicology Market For Dermal Toxicity, 2018 – 2030 (USD Million)
6.4 Endocrine Disruption
6.4.1 In-Vitro Toxicology Market For Endocrine Disruption, 2018 – 2030 (USD Million)
6.5 Ocular Toxicity
6.5.1 In-Vitro Toxicology Market For Ocular Toxicity, 2018 – 2030 (USD Million)
6.6 Other Applications
6.6.1 In-Vitro Toxicology Market For Other Applications, 2018 – 2030 (USD Million)
Chapter 7 Method Business Analysis
7.1 Global In Vitro Toxicology Testing Market: Method Movement Analysis
7.2 Cellular Assays
7.2.1 In-Vitro Toxicology Market For Cellular Assay, 2018 – 2030 (USD Million)
7.2.2 Live Cells
7.2.2.1 In-vitro toxicology market for live cells, 2018 – 2030 (USD Million)
7.2.2.2 High throughput / high content screening
7.2.2.2.1 High throughput / high content screening market for live cell-based in-vitro toxicology testing, 2018 – 2030 (USD Million)
7.2.2.3 Molecular imaging
7.2.2.3.1 Molecular imaging market for live cell-based in-vitro toxicology testing, 2018 – 2030 (USD Million)
7.2.2.3.2 Confocal microscopy
7.2.2.3.2.1 Confocal microscopy market for live cell-based in-vitro toxicology testing, 2018 – 2030 (USD Million)
7.2.2.3.3 Other molecular imaging technique
7.2.2.3.3.1 Other molecular imaging technique market for live cell-based in-vitro toxicology testing, 2018 – 2030 (USD Million)
7.2.2.4 Others
7.2.2.4.1 Live cell-based in-vitro toxicology testing market for other technologies, 2018 – 2030 (USD Million)
7.2.3 Fixed Cells
7.2.3.1 Fixed cell-based in-vitro toxicology testing market, 2018 – 2030 (USD Million)
7.3 Biochemical Assays
7.3.1 Biochemical Assays Market For In Vitro Toxicology Testing, 2018 – 2030 (USD Million)
7.4 In Silico
7.4.1 In Silico Assays Market For In Vitro Toxicology Testing, 2018 – 2030 (USD Million)
7.5 Ex Vivo
7.5.1 Ex Vivo Assays Market For In Vitro Toxicology Testing, 2018 – 2030 (USD Million)
Chapter 8 In-Vitro Toxicology Testing Market: Regional Business Analysis
8.1 In-Vitro Toxicology Testing Market: Regional Movement Analysis
8.2 North America
8.2.1 Swot Analysis
8.2.1.1 North America In-Vitro Toxicology Testing Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.2.2 U.S.
8.2.2.1 Key Country Dynamics
8.2.2.2 Competitive Scenario
8.2.2.3 U.S. In-Vitro Toxicology Testing Market, 2018 – 2030 (USD Million)
8.2.3 Canada
8.2.3.1 Key Country Dynamics
8.2.3.2 Competitive Scenario
8.2.3.3 Canada In-Vitro Toxicology Testing Market, 2018 – 2030 (USD Million)
8.3 Europe
8.3.1 Swot Analysis
8.3.1.1 Europe In-Vitro Toxicology Testing Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.3.2 Germany
8.3.2.1 Key Country Dynamics
8.3.2.2 Competitive Scenario
8.3.2.3 Germany In-Vitro Toxicology Testing Market, 2018 – 2030 (USD Million)
8.3.3 U.K.
8.3.3.1 Key Country Dynamics
8.3.3.2 Competitive Scenario
8.3.3.3 U.K. In-Vitro Toxicology Testing Market, 2018 – 2030 (USD Million)
8.3.4 France
8.3.4.1 Key Country Dynamics
8.3.4.2 Competitive Scenario
8.3.4.3 France In-Vitro Toxicology Testing Market, 2018 – 2030 (USD Million)
8.3.5 Italy
8.3.5.1 Key Country Dynamics
8.3.5.2 Competitive Scenario
8.3.5.3 Italy In-Vitro Toxicology Testing Market, 2018 – 2030 (USD Million)
8.3.6 Spain
8.3.6.1 Key Country Dynamics
8.3.6.2 Competitive Scenario
8.3.6.3 Spain In-Vitro Toxicology Testing Market, 2018 – 2030 (USD Million)
8.3.7 Denmark
8.3.7.1 Key Country Dynamics
8.3.7.2 Competitive Scenario
8.3.7.3 Denmark In-Vitro Toxicology Testing Market, 2018 – 2030 (USD Million)
8.3.8 Sweden
8.3.8.1 Key Country Dynamics
8.3.8.2 Competitive Scenario
8.3.8.3 Sweden In-Vitro Toxicology Testing Market, 2018 – 2030 (USD Million)
8.3.9 Norway
8.3.9.1 Key Country Dynamics
8.3.9.2 Competitive Scenario
8.3.9.3 Norway In-Vitro Toxicology Testing Market, 2018 – 2030 (USD Million)
8.4 Asia Pacific
8.4.1 Swot Analysis
8.4.1.1 Asia Pacific In-Vitro Toxicology Testing Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.4.2 Japan
8.4.2.1 Key Country Dynamics
8.4.2.2 Competitive Scenario
8.4.2.3 Japan In-Vitro Toxicology Testing Market, 2018 – 2030 (USD Million)
8.4.3 China
8.4.3.1 Key Country Dynamics
8.4.3.2 Competitive Scenario
8.4.3.3 China In-Vitro Toxicology Testing Market, 2018 – 2030 (USD Million)
8.4.4 India
8.4.4.1 Key Country Dynamics
8.4.4.2 Competitive Scenario
8.4.4.3 India In-Vitro Toxicology Testing Market, 2018 – 2030 (USD Million)
8.4.5 Australia
8.4.5.1 Key Country Dynamics
8.4.5.2 Competitive Scenario
8.4.5.3 Australia In-Vitro Toxicology Testing Market, 2018 – 2030 (USD Million)
8.4.6 Thailand
8.4.6.1 Key Country Dynamics
8.4.6.2 Competitive Scenario
8.4.6.3 Thailand In-Vitro Toxicology Testing Market, 2018 – 2030 (USD Million)
8.4.7 South Korea
8.4.7.1 Key Country Dynamics
8.4.7.2 Competitive Scenario
8.4.7.3 South Korea In-Vitro Toxicology Testing Market, 2018 – 2030 (USD Million)
8.5 Latin America
8.5.1 Swot Analysis
8.5.1.1 Latin America In-Vitro Toxicology Testing Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.5.2 Brazil
8.5.2.1 Key Country Dynamics
8.5.2.2 Competitive Scenario
8.5.2.3 Brazil In-Vitro Toxicology Testing Market, 2018 – 2030 (USD Million)
8.5.3 Mexico
8.5.3.1 Key Country Dynamics
8.5.3.2 Competitive Scenario
8.5.3.3 Mexico In-Vitro Toxicology Testing Market, 2018 – 2030 (USD Million)
8.5.4 Argentina
8.5.4.1 Key Country Dynamics
8.5.4.2 Competitive Scenario
8.5.4.3 Argentina In-Vitro Toxicology Testing Market, 2018 – 2030 (USD Million)
8.6 Middle East & Africa (MEA)
8.6.1 Swot Analysis
8.6.1.1 MEA In-Vitro Toxicology Testing Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.6.2 South Africa
8.6.2.1 Key Country Dynamics
8.6.2.2 Competitive Scenario
8.6.2.3 South Africa In-Vitro Toxicology Testing Market, 2018 – 2030 (USD Million)
8.6.3 Saudi Arabia
8.6.3.1 Key Country Dynamics
8.6.3.2 Competitive Scenario
8.6.3.3 Saudi Arabia In-Vitro Toxicology Testing Market, 2018-2030 (USD Million)
8.6.4 UAE
8.6.4.1 Key Country Dynamics
8.6.4.2 Competitive Scenario
8.6.4.3 UAE In-Vitro Toxicology Testing Market, 2018-2030 (USD Million)
8.6.5 Kuwait
8.6.5.1 Key Country Dynamics
8.6.5.2 Competitive Scenario
8.6.5.3 Kuwait In-Vitro Toxicology Testing Market, 2018-2030 (USD Million)
Chapter 9 Competitive Landscape
9.1 Participant’s Overview
9.1.1 Charles River Laboratories International, Inc.
9.1.2 Thermo Fisher Scientific, Inc.
9.1.3 Abbott Laboratories
9.1.4 Sgs S.A.
9.1.5 Laboratory Corporation Of America Holdings
9.1.6 Merck Kgaa
9.1.7 Eurofins Scientific
9.1.8 Evotec S.E.
9.1.9 Agilent Technolgies, Inc.
9.1.10 Quest Diagnostics Incorporated
9.1.11 Danaher Corporation
9.1.12 Bio-Rad Laboratories, Inc.
9.1.13 Catalent, Inc.
9.1.14 Bioivt
9.1.15 Gentronix
9.2 Financial Performance
9.3 Participant Categorization
9.3.1 Market Leaders
9.3.1.1 In-Vitro Toxicology Testing Market Share Analysis, 2022
9.3.2 Strategy Mapping
9.3.2.1 Expansion
9.3.2.2 Acquisition
9.3.2.3 Collaborations
9.3.2.4 Product/service launch
9.3.2.5 Partnerships
9.3.2.6 Others
|
| ※본 조사보고서 [세계의 체외 독성 검사 시장 (2023~2030) : 세포 배양, 하이 스루풋] (코드 : GRV23MA026) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 체외 독성 검사 시장 (2023~2030) : 세포 배양, 하이 스루풋] 에 대해서 E메일 문의는 여기를 클릭하세요. |
※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요!
